SPIA
FLNA

Steward Partners Investment Advisory’s Filana Therapeutics FLNA Stock Holding History

Steward Partners Investment Advisory’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$527 Hold
312
– – ﹤0.01% 4257
2025
Q4 		$618 Hold
312
– – ﹤0.01% 4134
2025
Q3 		$908 Buy
312
+200
+179% +$460 ﹤0.01% 4059
2025
Q2 		$203 Hold
112
– – ﹤0.01% 4025
2025
Q1 		$168 Hold
112
– – ﹤0.01% 3930
2024
Q4 		$264 Buy
112
+37
+49% +$650 ﹤0.01% 3891
2024
Q3 		$2.21K Hold
75
– – ﹤0.01% 3423
2024
Q2 		$926 Sell
75
-50
-40% -$1.05K ﹤0.01% 3403
2024
Q1 		$2.54K Hold
125
– – ﹤0.01% 3244
2023
Q4 		$2.81K Buy
125
+50
+67% +$1.06K ﹤0.01% 3141
2023
Q3 		$1.25K Hold
75
– – ﹤0.01% 3161
2023
Q2 		$1.84K Hold
75
– – ﹤0.01% 3040
2023
Q1 		$1.81K Hold
75
– – ﹤0.01% 3036
2022
Q4 		$2.22K Hold
75
– – ﹤0.01% 2997
2022
Q3 		$3K Hold
75
– – ﹤0.01% 2963
2022
Q2 		$2K Hold
75
– – ﹤0.01% 3038
2022
Q1 		$3K Sell
75
-158
-68% -$6.7K ﹤0.01% 3036
2021
Q4 		$10K Sell
233
-325
-58% -$17K ﹤0.01% 2608
2021
Q3 		$35K Buy
558
+358
+179% +$29.9K ﹤0.01% 2058
2021
Q2 		$17K Sell
200
-505
-72% -$27.1K ﹤0.01% 5312
2021
Q1 		$31.7K Buy
+705
New +$27.7K ﹤0.01% 2233

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Steward Partners Investment Advisory's FLNA Position: Q1 2026 in Review

Steward Partners Investment Advisory held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 312 shares worth $527. The position accounts for ﹤0.01% of the portfolio, ranked #4257.

Steward Partners Investment Advisory first reported a position in FLNA in Q1 2021 and has held it in 21 quarters since. The position peaked at $35K in Q3 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Steward Partners Investment Advisory held 312 shares of Filana Therapeutics worth $527 as of Q1 2026.
  • Steward Partners Investment Advisory left its Filana Therapeutics share count unchanged in Q1 2026.
  • Filana Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #4257 holding.
  • Steward Partners Investment Advisory first reported a position in Filana Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • Steward Partners Investment Advisory's Filana Therapeutics position peaked at $35K in Q3 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.